We believe that further investigation of salivary exosomes and miRNA expression assays might reveal more potential candidates of prostate cancer-associated circulating miRNAs enabling a non-invasive, saliva-based test method with high prognostic value to indicate prostate cancer and maybe replace PSA measurements in the long run. The gene discussed is KLK3; the disease is prostate cancer.